Rho-associated protein kinase inhibitors
TW202633885APending Publication Date: 2026-08-16ELI LILLY & CO +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW115114999
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-12-22
- Filing Date
- 2024-12-20
- Publication Date
- 2026-08-16
Abstract
The present disclosure provides compounds of the formula wherein moieties A2, A1, B, and substituents R1, R3, and R4 are as described herein pharmaceutically acceptable salts thereof, and methods of using these compounds and pharmaceutically acceptable salts thereof for treating patients for ROCK1 and ROCK2 modulated disorders.
Need to check novelty before this filing date? Find Prior Art